Related Experiment Videos
Hormone replacement therapy and inflammation: interactions in cardiovascular disease
Andrew P Miller1, Yiu-Fai Chen, Dongqi Xing
1Vascular Biology and Hypertension Program, Division of Cardiovascular Disease, Department of Medicine, The University of Alabama at Birmingham, 1047 Zeigler Research Bldg, 703 19th St South, Birmingham, AL 35294-0007, USA. apmiller@uab.edu
Hypertension (Dallas, Tex. : 1979)
|August 13, 2003
Summary
Menopausal hormone therapy impacts vascular inflammation markers, with varied effects depending on the hormone type and delivery method. Further animal studies are needed to clarify hormone effects on vascular disease pathogenesis.
Area of Science:
- Cardiovascular Science
- Endocrinology
- Inflammation Research
Background:
- Inflammation is key in vascular diseases like atherosclerosis, involving endothelial damage and the release of inflammatory markers.
- Menopausal hormone therapy influences various soluble inflammatory markers, generally showing negative modulatory effects on most, but with inconsistent or stimulatory effects on others.
- Oral conjugated estrogens increase C-reactive protein (CRP), a cardiovascular disease risk biomarker, unlike transdermal estrogen, suggesting a liver-specific effect.
Discussion:
- The differential effects of oral versus transdermal estrogen on CRP warrant further investigation regarding cardiovascular risk.
- Understanding the complex interplay between menopausal hormones, vascular inflammation, and atherosclerosis requires nuanced analysis.
- While some inflammatory markers decrease with hormone therapy, others like CRP show increases, necessitating careful interpretation.
Key Insights:
- Menopausal hormone therapy differentially affects vascular inflammation markers; most decrease, but CRP increases with oral administration.
- The rise in CRP with oral estrogen therapy may be a liver-mediated effect and not directly linked to increased cardiovascular risk.
- Estrogen's impact on vascular inflammation is complex, with some pathways showing protective effects (TGF-β) and others potentially detrimental ones.
Outlook:
- Animal models are crucial for elucidating the precise cellular and molecular mechanisms of hormone action on vascular health.
- Future research should focus on differentiating the effects of various hormone preparations and delivery routes on vascular disease.
- Investigating the long-term consequences of hormone-induced changes in inflammatory biomarkers is essential for clinical guidance.